The headache fellow at Cleveland Clinic outlined the design and reasoning for a new study assessing nerve blocks to treat COVID-19 headache.
Aarushi Suneja, MD
Advertisement
Articles by Aarushi Suneja, MD
The duo from Cleveland Clinic discussed their presentation from AHS 2021 regarding the effects of COVID-19 on access to telemedicine visits among minorities.
Advertisement
Latest Updated Articles
Improving Use of Telemedicine in Minority Communities: Aarushi Suneja, MD; Zubair Ahmed, MDPublished: July 4th 2021 | Updated:
Nerve Blocks for the Treatment of COVID-19 Headache: Aarushi Suneja, MDPublished: July 11th 2021 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Efgartigimod Effective in Seronegative gMG, Obexelimab Meets Primary End Point, FDA Accepts NDA for Tau Tracer MK-6240
2
NeurologyLive® Friday 5 — October 31, 2025
3
Designing the Phase 3 EMPEROR Trial and Future Considerations
4
Evaluating Combined Supraorbital and Occipital Neuromodulation in Phase 3 Trial for Resistant Migraine: The RECLAIM Study
5
